Home/Investors/Ascenta Capital

Ascenta Capital

Biotech Investor · 2 portfolio companies

Portfolio

2

Focus Areas

8

Top Stage

Phase 2

Investment Focus

Metabolic Diseases Liver Diseases Obesity Diabetes Dyslipidemias Cardiovascular Heart Failure Arrhythmias

Portfolio Companies

Company	Stage	Valuation	Focus
OrsoBio	Phase 2	—	Metabolic Diseases, Liver Diseases
Cardurion Pharmaceuticals	Phase 2	—	Cardiovascular, Heart Failure

Frequent Co-Investors

GV1 shared F-Prime Capital1 shared Bain Capital Life Sciences1 shared Samsara BioCapital1 shared Longitude Capital1 shared Eli Lilly (investor)1 shared NEA1 shared